Combined therapy with probiotic VSL#3 and Omega-3 fatty acids attenuates colonic injury and inflammation in chronic DNBS-induced colitis in mice

Özet

We published the abovementioned article about probiotic mixture VSL#3 on October 6, 2021. Since the product was named VSL#3 in our purchasing process in early 2016, it is referred to as VSL#3 in our article. In addition, the product currently known as VSL#3 is not the same as De Simone Formulation. De Simone Formulation is now available as Visbiome® in the United States and Vivomixx® in Europe. The authors would like to apologise for any inconvenience caused

Açıklama

Anahtar Kelimeler

Cytokines, Probiotic, Omega-3 fatty acid, Inflammatory bowel diseases, Colitis

Kaynak

Folia Biologica-Krakow

WoS Q Değeri

Q4

Scopus Q Değeri

Cilt

70

Sayı

1

Künye